The treatment of Diabetes & Eye Health with vitamins

Diabetes and Eye Health: Mitamins custom make quality formulas for the treatment of Diabetes & Eye Health with vitamins. A Diabetes & Eye Health formula will be made to suit you, using quality brand name ingredients. Mitamins produce custom made vitamin and supplement formulas to suit your individual health needs conveniently in one formula, one bottle and one dosage. For assistance, call toll free: 1-866-585-1390
Your Supplements Facts - Covers the formulas above
Supplement Facts

Specially Formulated for: Diabetes and Eye Health

  • Amount Per Serving
    % DV
    Vitamin A
    2500
    IU
    50%
    Vitamin C
    100
    mg
    167%
    Vitamin E
    100
    IU
    333%
    Zinc
    10
    mg
    67%
    Copper
    1
    mg
    50%
    Chromium
    400
    mcg
    333%
    Alpha Lipoic Acid
    50
    mg
    *
  • Amount Per Serving
    % DV
    Lutein
    1000
    mcg
    *
    Bilberry Extract
    50
    mg
    *
    Bioflavonoid Concentrate
    50
    mg
    *
    N-Acetyl L-Cysteine
    100
    mg
    *
    Taurine
    50
    mg
    *
    Amino Acid Mix
    50
    mg
    *
    * Daily Value (DV) not established
Name Your Supplement Bottle - Just how you like it
The current default name is: 
 
(Click in box to change)
Your Perfect Supplement - Custom-made just for you
Formulas form 35 Years of Medical Practice

Diabetes and Eye Health Formulas Details

Customize Your Supplements - Check all that apply
4A Select additional condition(s) you want to address:


4B Select all the medication(s) you are taking:
If your concern or medication is not listed here, use our Formulator, which covers 680 concerns and 1600 drugs, Click here!
Latest Health Related News:
Could Statins Be A New Option For Hepatitis C Patients?
Research presented today at Digestive Disease Week 2007 (DDW) demonstrates the potential of statins, important cholesterol management therapies, for improving the management of hepatitis C - a disease that affects nearly four million Americans. Although there have been no new treatments for hepatitis C since the introduction of pegylated interferon in 2001, the opportunity to develop a new generation of therapies that offer better outcomes may be imminent.
ERBITUX(R) Meets Primary Endpoint Of Increasing Survival In Phase III Lung Cancer Study
ImClone Systems Incorporated (Nasdaq: IMCL) and Bristol-Myers Squibb Company (NYSE: BMY) today announced that a Phase III study of ERBITUX(R) (Cetuximab) in combination with platinum-based chemotherapy (vinorelbine plus cisplatin) met its primary endpoint of increasing overall survival compared with chemotherapy alone in patients with advanced non-small cell lung cancer (NSCLC).
This information concerning the support of Diabetes and Eye Health treatments provide basic knowledge which should always be discussed with your own health practitioner.
Any Questions, Call Us Toll Free: 1-866-585-1390
Live Chat System

manufactured In USA

  verisign          Trust E Finalmark

Custom Vitamins and Nutritional Supplements for Supporting Age-Related Cognitive Decline and Aging Treatments